IL6 and metabolic dysfunction-associated steatotic liver disease: In terms of mechanism, the involvement of intrahepatic Th17 cells and serum IL-6, IL-17, and IL-23 has been demonstrated in a murine NASH model and human patients with NAFLD (33, 34).